Sullivan & Cromwell has advised B-Flexion. Boston Pharmaceuticals, owned by B-Flexion, has reached an agreement to sell its lead asset, efimosfermin alfa, to GSK for up...
B-Flexion Sells Boston Pharmaceuticals’ Lead Liver Disease Asset to GSK for Up to $2 Billion
Pacific Avenue Capital Partners’ Acquisition of Kidde-Fenwal Business
Raines Feldman Littrell advised Pacific Avenue Capital Partners, while Sullivan & Cromwell advised Kidde-Fenwal Business on the deal. Kidde-Fenwal obtained Bankruptcy Court approval for the sale...